رقم CAS
حمض الفوسيديك - 6990-06-3؛ الشائبة A - 80445-74-5؛ الشائبة B - غير متوفر؛ الشائبة C - غير متوفر؛ الشائبة D - 3054708-76-5؛ الشائبة F - 1415035-94-7؛ الشائبة G - 4680-37-9؛ الشائبة H - 16711-91-4؛ الشائبة N - 13090-91-0
الصيغة الجزيئية
حمض الفوسيديك - C31H48O6؛ IMP-A- C31H50O8؛ IMP-B- C31H48O7؛ IMP-C- C31H48O7؛ IMP-D-؛ IMP-F- C31H46O7؛ IMP-G- C31H46O6؛ IMP-H- C31H46O6؛ IMP-N- C29H46O5
وزن جزيئي
حمض الفوسيديك - 516.71؛ IMP-A - 550.72؛ IMP-B - 532.71 جم/مول؛ IMP-C - 532.71؛ IMP-D - 532.71 جم/مول؛ IMP-F - 530.69 جم/مول؛ IMP-G - 514.69 جم/مول؛ IMP-H - 514.7 جم/مول؛ IMP-N - 474.7 جم/مول
مرادف

Fusidic acid - (3alpha,4alpha,8alpha,9beta,11alpha,13alpha,147beta,167beta,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic Acid

Fusidic acid EP Impurity A - (3α,4α,8α,9β,11α,13α,14β,16β,17Z)-16-(Acetyloxy)-3,11,24,25-tetrahydroxy-29-nordammar-17(20)-en-21-oic Acid; 24,25-Dihydroxyfusidic Acid; 24,25-dihydroxyfusidic Acid;

Fusidic acid EP Impurity B - (3R,4S,5S,8S,9S,10S,11R,13R,14S,16S,Z)-3,11-Dihydroxy-17-((R)-6-hydroxy-7,7-dimethyl-2-oxooxepan-3-ylidene)-4,8,10,14-tetramethylhexadecahydro-1H-cyclopenta[a]phenanthren-16-yl Acetate;ent-(17Z)-3β,11β-Dihydroxy-17-[(6SR)-6-hydroxy-7,7-dimethyl-2-oxooxepan-3- ylidene]-4β,8,14-trimethyl-18-nor-5β,10α-androstan-16α-yl Acetate;

Fusidic acid EP Impurity C - (3R,4S,5S,8S,9S,10S,11R,13R,14S,16S,Z)-3,11-Dihydroxy-17-((R)-6-(2-hydroxypropan-2-yl)-2-oxodihydro-2H-pyran-3(4H)-ylidene)-4,8,10,14-tetramethylhexadecahydro-1H-cyclopenta[a]phenanthren-16-yl Acetate

Fusidic acid EP Impurity D - (3R,4S,5S,8S,9S,10S,11R,13R,14S,16S,Z)-3,11-Dihydroxy-17-((S)-6-(2-hydroxypropan-2-yl)-2-oxodihydro-2H-pyran-3(4H)-ylidene)-4,8,10,14-tetramethylhexadecahydro-1H-cyclopenta[a]phenanthren-16-yl Acetate ; ent-(17Z)-3beta,11beta-Dihydroxy-17-[(6R)-6-(1-hydroxy-1-methylethyl)-2-oxodihydro-2H-pyran-3(4H)-ylidene]-4beta,8,14-trimethyl-18-nor-5beta,10alpha-androstan-16alpha-yl acetate;(24S)-24,25-Dihydro-24,25-dihydroxyfusidic acid 21,24-lactone; Fusidic Acid Impurity D;

Fusidic acid EP Impurity F - 26-Oxofusidic Acid;(2Z,5E)-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihydroxy-4,8,10,14-tetramethyldodecahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-6-methyl-7-oxohept-5-enoic acid; Ent-(17Z,24EZ)-16alpha-(acetyloxy)-3beta,11beta-dihydroxy-4beta,8,14-trimethyl-26-oxo-18-nor-5beta,10alpha-cholesta-17(20),24-dien-21-oic acid;

Fusidic acid EP Impurity G - (4alpha,8alpha,9beta,11alpha,13alpha,14beta,16beta,17Z)-16-(Acetyloxy)-11-hydroxy-3-oxo-29-nordammara-17(20),24-dien-21-oic Acid; Ent-(17Z)-16α-(acetyloxy)-11β-hydroxy-4β,8,14-trimethyl-3-oxo-18-nor-5β,10α-cholesta-17(20),24-dien-21-oic acid;

Fusidic acid EP Impurity H - (3alpha,4alpha,8alpha,9beta,13alpha,14beta,16beta,17Z)-16-(Acetyloxy)-3-hydroxy-11-oxo-29-nordammara-17(20),24-dien-21-oic acid; Ent-(17Z)-16α-(acetyloxy)-3β-hydroxy-4β,8,14-trimethyl-11-oxo-18-nor-5β,10α-cholesta-17(20),24-dien-21-oic acid

Fusidic acid Impurity N - (Z)-6-Methyl-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-3,11,16-trihydroxy-4,8,10,14-tetramethylhexadecahydro-17H-cyclopenta[a]phenanthren-17-ylidene)hept-5-enoic acid

slide.1